E2open Acquires Global Multi-Carrier E-Commerce Shipping Software Platform, Logistyx Technologies. Read More

Logistyx President Ken Fleming: Pandemic “opened a lot of eyes to inherent fulfillment challenges”

Healthcare Purchasing News recently published an article exploring ways to future-proof the supply chain as we emerge from the global pandemic. Among the many experts cited is Logistyx President Ken Fleming, who argues the pandemic “opened a lot of eyes to inherent fulfillment challenges and exacerbated them for many.” Ken continues in the piece:

‘“Exploding e-commerce order volumes, increasing carrier capacity crunches, shipping surcharges and price increases, and, of course, heightened customer expectations for rapid and inexpensive shipping have all complicated order fulfillment and logistics for shippers around the world,” he observed.

“To effectively manage these and keep them from destroying both customer satisfaction and the bottom line, companies should implement a cloud-based multi-carrier parcel shipping solution, replete with advanced business intelligence,” Fleming said. “By integrating a multi-carrier shipping solution into a supply chain tech stack, companies no longer have to ship with just one or two carriers. Instead, they can tap into an extensive carrier network that includes dozens of regional carriers, making it easier and faster to add and maintain carriers’ rates and services and enabling them to quickly react to carrier capacity limitations, surcharges and rate increases to better control costs and maintain on-time deliveries.

“The ability to make business decisions based on shipping data has never been more important, especially considering the challenges of the last year,” he continued. “As companies strive to meet the demands of consumers, they must harness and leverage shipping data to identify and gain control of parcel shipping opportunities.”’

Read the full article at Healthcare Purchasing News for further insights from Ken and other experts on how to future-proof the supply chain to more effectively avoid and manage future disruptions.

Drug Supply Chain Security Act: Working with Trusted Partners to Ensure Industry Compliance

In 2013, the US Food and Drug Administration (FDA) signed the Drug Supply Chain Security Act (DSCSA) into law, establishing requirements for manufacturers, distributors and other entities involved in the drug supply chain for product tracing, product identifiers, authorized trading partners and product verification. With implementation over a 10-year period, the DSCSA enhances the FDA’s ability to help protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated or otherwise harmful. The system also improves detection and removal of potentially dangerous drugs from the drug supply chain to protect U.S. consumers.

Since its signing in 2013, the DSCSA has presented significant challenges for the pharmaceutical industry. To help the industry meet DSCSA requirements, companies throughout the supply chain have developed technology to ensure safety and security measures can be properly achieved in accordance with the FDA’s industry guidance.

Logistyx helps shippers in the pharma industry ensure that every parcel ships with the correct label and documentation, no matter the carrier, destination or product. Logistyx has integrated with a worldwide network of 550+ carrier services to provide regulatory compliance and certification for each shipment. When shipping a specialized product like pharmacological drugs that require extra documentation, Logistyx provides the necessary documents to comply with complex regulations like those required by the DSCSA.

While full implementation of the DSCSA goes into effect on November 27, 2023, the next major milestone for pharmaceutical companies and all trading partners within the pharmaceutical supply chain is coming up on November 27, 2020. As of that date, the FDA will enforce wholesalers to only accept and sell serialized products and verify the serialized number on all saleable returns, and dispensers to only accept serialized product.

For medical drug manufacturers and others involved in the pharma supply chain, it is critical to begin preparing their company for the next phase of DSCSA readiness and compliance, as well as asking questions of their strategic partners.

As stated in the FDA’s guidance document, “Identifying Trading Partners Under the Drug Supply Chain Security Act,” while serving as a solution provider that offers software or systems solutions to help achieve compliance with the requirements under DSCSA, Logistyx does not:

  • take ownership of the product nor direct the sale or disposition of a product
  • provide or coordinate warehousing
  • accept or transfer direct possession of the product

Therefore, Logistyx is not considered a 3PL under the DSCSA and is thus not required to be compliant with DSCSA regulations. However, we would advise shippers and suppliers of medical treatments and drugs in the pharma industry to ensure that certain types of partners are indeed compliant, if they may fit the 3PL licensure requirements under DSCSA in accordance with these guidelines.

To help manage the details of your specialized shipping needs and all the necessary labels, documents, and procedures to ensure compliance, contact us today.

Logistyx TME Streamlines Shipping

Bausch + Lomb standardize distribution – improving end-to-end visibility and saving at least half a day in labor costs every week.

As one of the most highly respected and well-known healthcare brands in the world, Bausch + Lomb needs to ensure the distribution of their products is smooth and seamless to maintain their integrity in the industry and keep their customers happy. However, a complex in-house system combined with huge growth within the organization was making this difficult to achieve. Having developed their own distribution tool in an attempt to streamline the order process, Bausch + Lomb was faced with all sorts of problems soon after implementation.


Carrier Management and Compliance – Bausch + Lomb were using 25 different carriers, each with their own different services and types of barcodes, which were not always compatible with Bausch + Lomb’s software. Label maintenance for this large number of carriers was extremely labor-intensive and was costing the company a lot of money. They needed a system that could link all of their carriers and enforce carrier compliance.

Tracking – Before adopting the Logistyx TME solution, Bausch + Lomb had to track thousands of items, all on different carrier sites, every week. This was extremely time-consuming and costly. The system was unable to track orders all the way through the delivery process and Bausch + Lomb couldn’t confidently inform customers of exact delivery times. They needed to streamline their processes so that they could efficiently manage distribution and improve the information flow.


Logistyx TME for parcel shipping supports the tariffs, services, and special fees for all carriers and links the information so that it is accessible via one system. This eliminates the need to work on different carrier sites and in different languages. Logistyx TME produces all of the appropriate shipping documentation including labels, manifests, and commercial invoices, eliminating manual document production. Logistyx TME reporting capabilities allow Bausch + Lomb to access all of the necessary performance data to provide the right information to the right people when they need it.


Logistyx TME has standardized Bausch + Lomb’s distribution. Operations are much more seamless and efficient. The company has reduced shipping costs while improving shipping visibility. The system:

  • Provides full visibility from order to delivery, all on one platform. This has saved Bausch + Lomb a lot of time, as previously they were tracking orders on each individual carrier site.
  • Helps Bausch + Lomb increase productivity, saving at least half a day in labor costs every week.
  • Provides tracking to provide customers with shipping status updates. As a result, Bausch + Lomb has improved customer satisfaction rates.

Please contact us for a complimentary consultation today. You can contact us by phone at 877-755-2374 or via the contact form.